Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
June-2021 Volume 23 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2021 Volume 23 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

H3K14 hyperacetylation‑mediated c‑Myc binding to the miR‑30a‑5p gene promoter under hypoxia postconditioning protects senescent cardiomyocytes from hypoxia/reoxygenation injury

  • Authors:
    • Lingbo Xu
    • Huiping Zhang
    • Yanhua Wang
    • Wei Guo
    • Lingyu Gu
    • Anning Yang
    • Shengchao Ma
    • Yong Yang
    • Kai Wu
    • Yideng Jiang
  • View Affiliations / Copyright

    Affiliations: Department of Pathophysiology, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China, Department of Prenatal Diagnosis Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China, Department of Gynecology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China, NHC Key Laboratory of Metabolic Cardiovascular Diseases Research, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China, Department of Nuclear Medicine, The People's Hospital in Ningxia Hui Autonomous Region, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China
    Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 468
    |
    Published online on: April 19, 2021
       https://doi.org/10.3892/mmr.2021.12107
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Our previous study reported that microRNA (miR)‑30a‑5p upregulation under hypoxia postconditioning (HPostC) exert a protective effect on aged H9C2 cells against hypoxia/reoxygenation injury via DNA methyltransferase 3B‑induced DNA hypomethylation at the miR‑30a‑5p gene promoter. This suggests that miR‑30a‑5p may be a potential preventative and therapeutic target for ischemic heart disease in aged myocardium. The present study aimed to investigate the underlying mechanisms of miR‑30a‑5p transcription in aged myocardium in ischemic heart disease. Cardiomyocytes were treated with 8 mg/ml D‑galactose for 9 days, and then exposed to hypoxic conditions. Cell viability was determined using a cell viability assay. Expression levels of histone deacetylase 2 (HDAC2), LC3B‑II/I, beclin‑1 and p62 were detected via reverse transcription‑quantitative PCR and western blotting. Chromatin immunoprecipitation‑PCR and luciferase reporter assays were performed to evaluate the effect of c‑Myc binding and activity on the miR‑30a‑5p promoter in senescent cardiomyocytes following HPostC. It was found that HPostC enhanced the acetylation levels of H3K14 at the miR‑30a‑5p gene promoter in senescent cardiomyocytes, which attributed to the decreased expression of HDAC2. In addition, c‑Myc could positively regulate miR‑30a‑5p transcription to inhibit senescent cardiomyocyte autophagy. Mechanically, it was observed that increased H3K14 acetylation level exposed to romidepsin facilitated c‑Myc binding to the miR‑30a‑5p gene promoter region, which led to the increased transcription of miR‑30a‑5p. Taken together, these results demonstrated that HDAC2‑mediated H3K14 hyperacetylation promoted c‑Myc binding to the miR‑30a‑5p gene promoter, which contributed to HPostC senescent cardioprotection.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Curran J, Burkhoff D and Kloner RA: Beyond reperfusion: Acute ventricular unloading and cardioprotection during myocardial infarction. J Cardiovasc Transl Res. 12:95–106. 2019. View Article : Google Scholar : PubMed/NCBI

2 

Akhmedov A, Montecucco F, Costantino S, Vdovenko D, Schaub Clerigué A, Gaul DS, Burger F, Roth A, Carbone F, Liberale L, et al: Cardiomyocyte-specific JunD overexpression increases infarct size following ischemia/reperfusion cardiac injury by downregulating Sirt3. Thromb Haemost. 120:168–180. 2020. View Article : Google Scholar : PubMed/NCBI

3 

Zhang YM, Zhang ZY and Wang RX: Protective mechanisms of quercetin against myocardial ischemia reperfusion injury. Front Physiol. 11:9562020. View Article : Google Scholar : PubMed/NCBI

4 

Zhao R, Xie E, Yang X and Gong B: Alliin alleviates myocardial ischemia-reperfusion injury by promoting autophagy. Biochem Biophys Res Commun. 512:236–243. 2019. View Article : Google Scholar : PubMed/NCBI

5 

Zhang XY, Huang Z, Li QJ, Zhong GQ, Meng JJ, Wang DX and Tu RH: Ischemic postconditioning attenuates the inflammatory response in ischemia/reperfusion myocardium by upregulating miR-499 and inhibiting TLR2 activation. Mol Med Rep. 22:209–218. 2020. View Article : Google Scholar : PubMed/NCBI

6 

Wei L, Liang H, Mo M, Liu Z, Ye R, Ye H, Ouyang W, Yu W, Zhao W and Zhang X: The effect of remote ischemic postconditioning on autonomic function in patients with acute ischemic stroke: A randomized controlled trail. Complement Ther Med. 54:1025412020. View Article : Google Scholar : PubMed/NCBI

7 

Zhang C, Liao P, Liang R, Zheng X and Jian J: Epigallocatechin gallate prevents mitochondrial impairment and cell apoptosis by regulating miR-30a/p53 axis. Phytomedicine. 61:1528452019. View Article : Google Scholar : PubMed/NCBI

8 

Wang Y, Hao Y, Zhang H, Xu L, Ding N, Wang R, Zhu G, Ma S, Yang A, Yang Y, et al: DNA Hypomethylation of miR-30a mediated the protection of hypoxia postconditioning against aged cardiomyocytes hypoxia/reoxygenation injury through inhibiting autophagy. Circ J. 84:616–625. 2020. View Article : Google Scholar : PubMed/NCBI

9 

Kao SH, Cheng WC, Wang YT, Wu HT, Yeh HY, Chen YJ, Tsai MH and Wu KJ: Regulation of miRNA biogenesis and histone modification by K63-polyubiquitinated DDX17 controls cancer stem-like features. Cancer Res. 79:2549–2563. 2019.PubMed/NCBI

10 

Rymen B, Kawamura A, Lambolez A, Inagaki S, Takebayashi A, Iwase A, Sakamoto Y, Sako K, Favero DS, Ikeuchi M, et al: Histone acetylation orchestrates wound-induced transcriptional activation and cellular reprogramming in Arabidopsis. Commun Biol. 2:4042019. View Article : Google Scholar : PubMed/NCBI

11 

Wei F, Tang D, Li Z, Kashif MH, Khan A, Lu H, Jia R and Chen P: Molecular cloning and subcellular localization of six HDACs and their roles in response to salt and drought stress in kenaf (Hibiscus cannabinus L.). Biol Res. 52:202019. View Article : Google Scholar : PubMed/NCBI

12 

Yuan H, Li H, Yu P, Fan Q, Zhang X, Huang W, Shen J, Cui Y and Zhou W: Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury. BMC Ophthalmol. 18:3002018. View Article : Google Scholar : PubMed/NCBI

13 

Zhao TC, Cheng G, Zhang LX, Tseng YT and Padbury JF: Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovasc Res. 76:473–481. 2007. View Article : Google Scholar : PubMed/NCBI

14 

Wang Y, Liu H, Liu X, Zhang X, Wu J, Yuan L, Du X, Wang R, Ma Y, Chen X, et al: Histone acetylation plays an important role in MC-LR-induced apoptosis and cycle disorder in SD rat testicular cells. Chemosphere. 241:1250732020. View Article : Google Scholar : PubMed/NCBI

15 

Parrot C, Kurbegovic A, Yao G, Couillard M, Côté O and Trudel M: c-Myc is a regulator of the PKD1 gene and PC1-induced pathogenesis. Hum Mol Genet. 28:751–763. 2019. View Article : Google Scholar : PubMed/NCBI

16 

Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, Inoue H, Yamashita JK, Todani M, Nakagawa M, et al: Induced pluripotent stem cells and their use in human models of disease and development. Physiol Rev. 99:79–114. 2019. View Article : Google Scholar : PubMed/NCBI

17 

Saravia J, Zeng H, Dhungana Y, Bastardo Blanco D, Nguyen TM, Chapman NM, Wang Y, Kanneganti A, Liu S, Raynor JL, et al: Homeostasis and transitional activation of regulatory T cells require c-Myc. Sci Adv. 6:eaaw64432020. View Article : Google Scholar : PubMed/NCBI

18 

Zhang L, Fu Y and Guo H: c-Myc-induced long non-coding RNA small nucleolar RNA host gene 7 regulates glycolysis in breast cancer. J Breast Cancer. 22:533–547. 2019. View Article : Google Scholar : PubMed/NCBI

19 

Lee EJ, Seo E, Kim JW, Nam SA, Lee JY, Jun J, Oh S, Park M, Jho EH, Yoo KH, et al: TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease. Proc Natl Acad Sci USA. 117:29001–29012. 2020. View Article : Google Scholar : PubMed/NCBI

20 

Chen S, Bu D, Ma Y, Zhu J, Chen G, Sun L, Zuo S, Li T, Pan Y, Wang X, et al: H19 overexpression induces resistance to 1,25(OH)2D3 by targeting VDR through miR-675-5p in colon cancer cells. Neoplasia. 19:226–236. 2017. View Article : Google Scholar : PubMed/NCBI

21 

Guo W, Zhang H, Yang A, Ma P, Sun L, Deng M, Mao C, Xiong J, Sun J, Wang N, et al: Homocysteine accelerates atherosclerosis by inhibiting scavenger receptor class B member1 via DNMT3b/SP1 pathway. J Mol Cell Cardiol. 138:34–48. 2020. View Article : Google Scholar : PubMed/NCBI

22 

UniProt C: UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 49:D480–D489. 2021. View Article : Google Scholar : PubMed/NCBI

23 

Wen Z, Lian L, Ding H, Hu Y, Xiao Z, Xiong K and Yang Q: LncRNA ANCR promotes hepatocellular carcinoma metastasis through upregulating HNRNPA1 expression. RNA Biol. 17:381–394. 2020. View Article : Google Scholar : PubMed/NCBI

24 

Chen K, Miller EJ and Sadeghi MM: PET-based imaging of ischemic heart disease. PET Clin. 14:211–221. 2019. View Article : Google Scholar : PubMed/NCBI

25 

Li C, Mu N, Gu C, Liu M, Yang Z, Yin Y, Chen M, Wang Y, Han Y, Yu L and Ma H: Metformin mediates cardioprotection against aging-induced ischemic necroptosis. Aging Cell. 19:e130962020. View Article : Google Scholar : PubMed/NCBI

26 

Webster I, Salie R, Marais E, Fan WJ, Maarman G, Huisamen B and Lochner A: Myocardial susceptibility to ischaemia/reperfusion in obesity: A re-evaluation of the effects of age. BMC Physiol. 17:32017. View Article : Google Scholar : PubMed/NCBI

27 

Griecsová L, Farkašová V, Gáblovský I, Khandelwal VK, Bernátová I, Tatarková Z, Kaplan P and Ravingerová T: Effect of maturation on the resistance of rat hearts against ischemia. Study of potential molecular mechanisms. Physiol Res. 64 (Suppl):S685–S696. 2015. View Article : Google Scholar

28 

O'Brien JD, Ferguson JH and Howlett SE: Effects of ischemia and reperfusion on isolated ventricular myocytes from young adult and aged Fischer 344 rat hearts. Am J Physiol Heart Circ Physiol. 294:H2174–H1783. 2008. View Article : Google Scholar

29 

Bayrami G, Karimi P, Agha-Hosseini F, Feyzizadeh S and Badalzadeh R: Effect of ischemic postconditioning on myocardial function and infarct size following reperfusion injury in diabetic rats pretreated with vildagliptin. J Cardiovasc Pharmacol Ther. 23:174–183. 2018. View Article : Google Scholar : PubMed/NCBI

30 

Chávez MN, Morales RA, López-Crisosto C, Roa JC, Allende ML and Lavandero S: Autophagy activation in zebrafish heart regeneration. Sci Rep. 10:21912020. View Article : Google Scholar

31 

Shi B, Ma M, Zheng Y, Pan Y and Lin X: mTOR and Beclin1: Two key autophagy-related molecules and their roles in myocardial ischemia/reperfusion injury. J Cell Physiol. 234:12562–12568. 2019. View Article : Google Scholar : PubMed/NCBI

32 

Torres-Esquivel C, Montiel T, Flores-Méndez M and Massieu L: Effect of β-hydroxybutyrate on autophagy dynamics during severe hypoglycemia and the hypoglycemic coma. Front Cell Neurosci. 14:5472152020. View Article : Google Scholar : PubMed/NCBI

33 

Chen C, Li J, Zhang W, Shah SWA and Ishfaq M: Mycoplasma gallisepticum triggers immune damage in the chicken thymus by activating the TLR-2/MyD88/NF-κB signaling pathway and NLRP3 inflammasome. Vet Res. 51:522020. View Article : Google Scholar : PubMed/NCBI

34 

Huang Y, Liao Y, Zhang H and Li S: Lead exposure induces cell autophagy via blocking the Akt/mTOR signaling in rat astrocytes. J Toxicol Sci. 45:559–567. 2020. View Article : Google Scholar : PubMed/NCBI

35 

Liu Y, Song A, Wu H, Sun Y and Dai M: Paeonol inhibits apoptosis of vascular smooth muscle cells via up-regulation of autophagy by activating class III PI3K/Beclin-1 signaling pathway. Life Sci. 264:1187142021. View Article : Google Scholar : PubMed/NCBI

36 

Campbell GR, Bruckman RS, Chu YL, Trout RN and Spector SA: SMAC mimetics induce autophagy-dependent apoptosis of HIV-1-infected resting memory CD4+ T cells. Cell Host Microbe. 24:689–702.e7. 2018. View Article : Google Scholar : PubMed/NCBI

37 

Zhang J, Zhang X, Cui Y, Ferdous M, Cui L and Zhao P: Different postconditioning cycles affect prognosis of aged patients undergoing primary percutaneous coronary intervention. Cardiol J. 25:666–673. 2018.PubMed/NCBI

38 

Slettom G, Jonassen AK, Dahle GO, Seifert R, Larsen TH, Berge RK and Nordrehaug JE: Insulin postconditioning reduces infarct size in the porcine heart in a dose-dependent manner. J Cardiovasc Pharmacol Ther. 22:179–188. 2017. View Article : Google Scholar : PubMed/NCBI

39 

Maciejak A, Kostarska-Srokosz E, Gierlak W, Dluzniewski M, Kuch M, Marchel M, Opolski G, Kiliszek M, Matlak K, Dobrzycki S, et al: Circulating miR-30a-5p as a prognostic biomarker of left ventricular dysfunction after acute myocardial infarction. Sci Rep. 8:98832018. View Article : Google Scholar : PubMed/NCBI

40 

Lv XB, Niu QH, Zhang M, Feng L and Feng J: Critical functions of microRNA-30a-5p-E2F3 in cardiomyocyte apoptosis induced by hypoxia/reoxygenation. Kaohsiung J Med Sci. 37:92–100. 2021. View Article : Google Scholar : PubMed/NCBI

41 

Ding H, Wang Y, Hu L, Xue S, Wang Y, Zhang L, Zhang Y, Qi H, Yu H, Aung LHH, et al: Combined detection of miR-21-5p, miR-30a-3p, miR-30a-5p, miR-155-5p, miR-216a and miR-217 for screening of early heart failure diseases. Biosci Rep. 40:BSR201916532020. View Article : Google Scholar : PubMed/NCBI

42 

Zhao DS, Chen Y, Jiang H, Lu JP, Zhang G, Geng J, Zhang Q, Shen JH, Zhou X, Zhu W and Shan QJ: Serum miR-210 and miR-30a expressions tend to revert to fetal levels in Chinese adult patients with chronic heart failure. Cardiovasc Pathol. 22:444–450. 2013. View Article : Google Scholar : PubMed/NCBI

43 

Li D, Wang J, Hou J, Fu J, Liu J and Lin R: Salvianolic acid B induced upregulation of miR-30a protects cardiac myocytes from ischemia/reperfusion injury. BMC Complement Altern Med. 16:3362016. View Article : Google Scholar : PubMed/NCBI

44 

Shen Y, Shen Z, Miao L, Xin X, Lin S, Zhu Y, Guo W and Zhu YZ: miRNA-30 family inhibition protects against cardiac ischemic injury by regulating cystathionine-γ-lyase expression. Antioxid Redox Signal. 22:224–240. 2015. View Article : Google Scholar : PubMed/NCBI

45 

Long G, Wang F, Duan Q, Yang S, Chen F, Gong W, Yang X, Wang Y, Chen C and Wang DW: Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS One. 7:e509262012. View Article : Google Scholar : PubMed/NCBI

46 

Kubiak M, Jurek A, Kamińska K, Kowalewski J, Huang S and Lewandowska MA: Chromosome conformation capture reveals two elements that interact with the PTBP3 (ROD1) transcription start site. Int J Mol Sci. 20:2422019. View Article : Google Scholar : PubMed/NCBI

47 

Lee J and Lee TH: How protein binding sensitizes the nucleosome to histone H3K56 acetylation. ACS Chem Biol. 14:506–515. 2019. View Article : Google Scholar : PubMed/NCBI

48 

Hu Y, Lai Y, Chen X, Zhou DX and Zhao Y: Distribution pattern of histone marks potentially determines their roles in transcription and RNA processing in rice. J Plant Physiol. 249:1531672020. View Article : Google Scholar : PubMed/NCBI

49 

Narita T, Weinert BT and Choudhary C: Functions and mechanisms of non-histone protein acetylation. Nature reviews. Mol Cell Biol. 20:156–174. 2019.PubMed/NCBI

50 

Okonkwo A, Mitra J, Johnson GS, Li L, Dashwood WM, Hegde ML, Yue C, Dashwood RH and Rajendran P: Heterocyclic analogs of sulforaphane trigger DNA damage and impede DNA repair in colon cancer cells: Interplay of HATs and HDACs. Mol Nutr Food Res. 62:e18002282018. View Article : Google Scholar : PubMed/NCBI

51 

Han KA, Shin WH, Jung S, Seol W, Seo H, Ko C and Chung KC: Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation. Hum Mol Genet. 26:1–18. 2017.PubMed/NCBI

52 

Bascom GD and Schlick T: Chromatin fiber folding directed by cooperative histone tail acetylation and linker histone binding. Biophys J. 114:2376–2385. 2018. View Article : Google Scholar : PubMed/NCBI

53 

Church M, Smith KC, Alhussain MM, Pennings S and Fleming AB: Sas3 and Ada2(Gcn5)-dependent histone H3 acetylation is required for transcription elongation at the de-repressed FLO1 gene. Nucleic Acids Res. 45:4413–4430. 2017.PubMed/NCBI

54 

Zhang BL, Guo TW, Gao LL, Ji GQ, Gu XH, Shao YQ, Yao RQ and Gao DS: Egr-1 and RNA POL II facilitate glioma cell GDNF transcription induced by histone hyperacetylation in promoter II. Oncotarget. 8:45105–45116. 2017. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xu L, Zhang H, Wang Y, Guo W, Gu L, Yang A, Ma S, Yang Y, Wu K, Jiang Y, Jiang Y, et al: H3K14 hyperacetylation‑mediated c‑Myc binding to the miR‑30a‑5p gene promoter under hypoxia postconditioning protects senescent cardiomyocytes from hypoxia/reoxygenation injury. Mol Med Rep 23: 468, 2021.
APA
Xu, L., Zhang, H., Wang, Y., Guo, W., Gu, L., Yang, A. ... Jiang, Y. (2021). H3K14 hyperacetylation‑mediated c‑Myc binding to the miR‑30a‑5p gene promoter under hypoxia postconditioning protects senescent cardiomyocytes from hypoxia/reoxygenation injury. Molecular Medicine Reports, 23, 468. https://doi.org/10.3892/mmr.2021.12107
MLA
Xu, L., Zhang, H., Wang, Y., Guo, W., Gu, L., Yang, A., Ma, S., Yang, Y., Wu, K., Jiang, Y."H3K14 hyperacetylation‑mediated c‑Myc binding to the miR‑30a‑5p gene promoter under hypoxia postconditioning protects senescent cardiomyocytes from hypoxia/reoxygenation injury". Molecular Medicine Reports 23.6 (2021): 468.
Chicago
Xu, L., Zhang, H., Wang, Y., Guo, W., Gu, L., Yang, A., Ma, S., Yang, Y., Wu, K., Jiang, Y."H3K14 hyperacetylation‑mediated c‑Myc binding to the miR‑30a‑5p gene promoter under hypoxia postconditioning protects senescent cardiomyocytes from hypoxia/reoxygenation injury". Molecular Medicine Reports 23, no. 6 (2021): 468. https://doi.org/10.3892/mmr.2021.12107
Copy and paste a formatted citation
x
Spandidos Publications style
Xu L, Zhang H, Wang Y, Guo W, Gu L, Yang A, Ma S, Yang Y, Wu K, Jiang Y, Jiang Y, et al: H3K14 hyperacetylation‑mediated c‑Myc binding to the miR‑30a‑5p gene promoter under hypoxia postconditioning protects senescent cardiomyocytes from hypoxia/reoxygenation injury. Mol Med Rep 23: 468, 2021.
APA
Xu, L., Zhang, H., Wang, Y., Guo, W., Gu, L., Yang, A. ... Jiang, Y. (2021). H3K14 hyperacetylation‑mediated c‑Myc binding to the miR‑30a‑5p gene promoter under hypoxia postconditioning protects senescent cardiomyocytes from hypoxia/reoxygenation injury. Molecular Medicine Reports, 23, 468. https://doi.org/10.3892/mmr.2021.12107
MLA
Xu, L., Zhang, H., Wang, Y., Guo, W., Gu, L., Yang, A., Ma, S., Yang, Y., Wu, K., Jiang, Y."H3K14 hyperacetylation‑mediated c‑Myc binding to the miR‑30a‑5p gene promoter under hypoxia postconditioning protects senescent cardiomyocytes from hypoxia/reoxygenation injury". Molecular Medicine Reports 23.6 (2021): 468.
Chicago
Xu, L., Zhang, H., Wang, Y., Guo, W., Gu, L., Yang, A., Ma, S., Yang, Y., Wu, K., Jiang, Y."H3K14 hyperacetylation‑mediated c‑Myc binding to the miR‑30a‑5p gene promoter under hypoxia postconditioning protects senescent cardiomyocytes from hypoxia/reoxygenation injury". Molecular Medicine Reports 23, no. 6 (2021): 468. https://doi.org/10.3892/mmr.2021.12107
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team